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Introduction
The endoplasmic reticulum (ER) is a major site of protein fold-
ing and assembly in eukaryotes. Polypeptides entering the ER 
often encounter various folding problems, resulting in aggre-
gated or misfolded proteins. To preserve ER homeostasis, 
  eukaryotes have evolved a conserved quality control pathway 
termed retrotranslocation, dislocation, or ER-associated protein 
degradation (ERAD), which effi  ciently eliminates misfolded 
ER proteins by exporting them into the cytosol for degradation 
by the ubiquitin–proteasome system (Meusser et al., 2005).
Retrotranslocation is initiated when misfolded polypep-
tides are selectively targeted to the site of translocation at the ER 
membrane from where they are subsequently dislocated into the 
cytosol. The export of a subset of substrates requires the Derlin 
proteins, members of a highly conserved multi-spanning mem-
brane protein family postulated to form a channel (Lilley and 
Ploegh, 2004; Ye et al., 2004; Oda et al., 2006). Other substrates 
might use different routes to exit the ER. Most substrates under-
going retrotranslocation are modifi  ed by polyubiquitination, which 
is achieved by the sequential action of a ubiquitin-activating 
  enzyme (E1), a ubiquitin-conjugating enzyme (E2), and a 
  ubiquitin ligase (E3) (Meusser et al., 2005). Polyubiquitination 
  occurs at the cytosolic side of the ER membrane after a portion 
of the substrate has emerged into the cytosol. This modifi  cation 
is required for the subsequent dislocation of polyubiquitinated 
substrates from the ER membrane, a process that is mediated 
by the p97–Ufd1–Npl4 ATPase complex (Bays and Hampton, 
2002). During Derlin-dependent retrotranslocation, the ATPase 
complex is recruited to the Derlins together with a single spanning 
membrane protein called VIMP and certain ER-specifi  c ubiquitin 
ligases (Ye et al., 2004, 2005; Lilley and Ploegh, 2005). The 
  assembly of a retrotranslocation complex containing both the 
“pulling” ATPase p97 and the ubiquitination machinery ensures 
that substrate ubiquitination and dislocation are tightly coupled. 
For misfolded glycoproteins, their dislocation is also associated 
with the removal of the attached N-linked glycan by a cytosolic 
N-glycanase (Kim et al., 2006).
After entering the cytosol, polypeptides need to be trans-
ferred to the proteasome for degradation. This process is poorly 
defi  ned.  In  Saccharomyces cerevisiae, the p97 homologue 
cdc48p does not seem to form a stable complex with the 26S 
proteasome (Verma et al., 2000). Substrates bound by p97 
thus need to be shuttled to the proteasome, which likely involves 
interactions between ubiquitin conjugates and various ubiquitin 
binding proteins (Richly et al., 2005). Several proteasome-
  associated proteins such as rad23p in yeast contain ubiquitin 
binding motifs (Elsasser and Finley, 2005), and can serve as 
 receptors to collect ubiquitinated substrates (Verma et al., 2004). 
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isfolded proteins of the endoplasmic reticulum 
undergo retrotranslocation to enter the cytosol 
where they are degraded by the proteasome. 
Retrotranslocation of many substrates requires an ATPase 
complex consisting of the p97 ATPase and a dimeric cofac-
tor, Ufd1-Npl4. We report that efﬁ   cient elimination of 
  misfolded ER proteins also involves ataxin-3 (atx3), a 
p97-associated deubiquitinating enzyme mutated in type-3 
spinocerebellar ataxia. Overexpression of an atx3 mutant 
defective in deubiquitination inhibits the degradation of 
misfolded ER proteins and triggers ER stress. Misfolded 
  polypeptides stabilized by mutant atx3 are accumulated in 
part as polyubiquitinated form, suggesting an involvement 
of its deubiquitinating activity in ER-associated protein deg-
radation regulation. We demonstrate that atx3 transiently 
associates with the ER membrane via p97 and the recently 
identiﬁ  ed Derlin–VIMP complex, and its release from the 
membrane appears to be governed by both the p97 ATPase 
cycle and its own deubiquitinating activity. We present evi-
dence that atx3 may promote p97-associated deubiqui-
tination to facilitate the transfer of polypeptides from p97 to 
the proteasome.
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However, little is known about the “shuttling factors” that deliver 
substrates to these receptors. One candidate for a shuttling factor 
is ataxin-3 (atx3) (Kuhlbrodt et al., 2005),  a poly-glutamine 
(poly-Q) containing deubiquitinating enzyme (DUB) that inter-
acts with both p97, and HHR23A and B,   mammalian homo-
logues of rad23p (Wang et al. 2000; Doss-Pepe et al., 2003; 
Matsumoto et al., 2004; Boeddrich et al., 2006). Expansion of 
the poly-Q segment in atx3 has been linked to a dominantly 
  inherited form of spinocerebellar ataxia, a member of the poly-Q–
induced family of neurodegenerative diseases (Kawaguchi et al., 
1994), but how such poly-Q expansion causes the disease is 
  unclear. In addition, although the enzymatic activity of atx3 has 
been extensively characterized (Burnett et al., 2003; Chow et al., 
2004; Berke et al., 2005; Mao et al., 2005), its physiological 
function remains elusive. This study was initiated to explore the 
potential involvement of atx3 in ERAD. We conclude that atx3 
acts in conjunction with p97 to regulate the degradation of mis-
folded ER proteins.
Results
Interaction of ataxin-3 with the p97 complex
To test the potential involvement of atx3 in ERAD, we fi  rst 
characterized its interaction with p97 using purifi  ed components. 
Indeed, recombinant protein containing the GST fused to atx3 
(GST-atx3) bound purifi  ed wild-type (wt) p97 as well as several 
p97 variants that were defective either in ATP binding (AA and KA) 
or in ATP hydrolysis (QQ) (Ye et al., 2003). In contrast, a p97 
mutant lacking its N-terminal domain (N-domain) failed to bind 
GST-atx3 (Fig. 1 A). These results suggest that atx3 binds p97 
via its N-domain. Because many cofactors bind the p97 
N-domain in a mutually exclusive manner (Meyer et al., 2000), 
we tested whether atx3 would infl  uence the interaction of p97 
with Ufd1–Npl4 (U/N), a binary cofactor complex required for 
ERAD. Recombinant p97 was incubated with purifi  ed U/N in 
the presence of increased concentrations of either GST-atx3 or 
of a recombinant protein containing the GST fused to SVIP, 
a small p97 cofactor of unknown function (Nagahama et al., 
2003). The p97–Ufd1–Npl4 complex immunoprecipitated with 
anti-Ufd1 antibodies was analyzed by immunoblotting. As pre-
viously reported (Nagahama et al., 2003), addition of SVIP 
  resulted in reduced association of p97 with U/N, presumably 
because these cofactors compete for the same binding site on 
p97 (Fig. 1 B, lanes 5–7). In contrast, GST-atx3 did not affect 
the assembly of the p97–Ufd1–Npl4 complex (Fig. 1 B, lanes 
1–4), suggesting that atx3 either uses a different mode to inter-
act with the p97 N-domain or binds p97 with an affi  nity signifi  -
cantly lower than other cofactors. The lack of competition 
between atx3 and U/N raises the possibility that these cofactors 
may act in conjunction with p97 to regulate ERAD.
Interaction of ataxin-3 with components 
of the ERAD pathway
Therefore, we tested whether atx3 also interacts with other 
known components of the ERAD pathway, such as the recently 
identifi  ed Derlin–VIMP complex. Detergent extracts of 293T 
cells expressing FLAG-tagged atx3 were subjected to immuno-
precipitation with anti-FLAG antibodies. Immunoblotting with 
specifi  c antibodies showed that a fraction of Derlin-1, VIMP, 
and p97 was coprecipitated with atx3 (Fig. 2 A, lane 4). Endogenous 
atx3 could be coimmunoprecipitated with Derlin-1 and p97 
from detergent extract of dog pancreatic ER membranes (Fig. 
2 B, lane 3). When FLAG-tagged atx3 was coexpressed with 
Myc-tagged Hrd1, an ER-specifi   c ubiquitin ligase (Bays 
et al., 2001), both proteins could be coimmunoprecipitated (Fig. 
2 C). Together, these data suggest that a fraction of atx3 is asso-
ciated with the ER membranes via interactions with compo-
nents of the retrotranslocation machinery, including Derlin-1, 
VIMP, p97, and an ER-specifi  c ubiquitin ligase. Because only 
a small fraction of the Derlin complex could be coprecipitated 
with atx3, and immunoprecipitation using the VIMP antibody 
pulled down little atx3 (see Fig. 5 A), atx3 appears to transiently 
interact with the ER membrane (see Discussion).
Dominant-negative atx3 interferes 
with ER degradation
Because knock-down of atx3 by  80% using atx3-specifi  c 
siRNA was not suffi   cient to cause an apparent defect in 
Figure 1.  Interaction of atx3 with the p97 complex. (A) atx3 binds p97 
via its N-domain. A GST fusion protein containing wt atx3 was immobi-
lized on glutathione beads and incubated with either wild-type p97 
(p97 wt) or various p97 mutants as indicated. Bound proteins were sepa-
rated by SDS-PAGE and stained with Coomassie blue. A fraction of the 
binding reaction was analyzed directly by SDS-PAGE (input). (B) atx3 and 
Ufd1–Npl4 do not compete for binding to p97. p97 was incubated with 
puriﬁ  ed Ufd1–Npl4 in the presence of increased concentration of either 
GST-atx3 or GST-SVIP. The p97 complex was immunoprecipitated with 
anti-Ufd1 antibodies and analyzed by immunoblotting.ATAXIN-3 REGULATES ER-ASSOCIATED PROTEIN DEGRADATION • WANG ET AL. 965
  retrotranslocation (Fig. S1, available at http://www.jcb.org/cgi/
content/full/jcb.200605100/DC1), we attempted to interfere 
with the function of endogenous atx3 with a catalytically  inac-
tive atx3 mutant (atx3 C14A). We reasoned that this atx3 variant 
was likely to exert a dominant-negative effect because it binds 
ubiquitinated substrates with high affi  nity, but cannot process 
them (Burnett et al., 2003). We fi  rst tested whether the expres-
sion of atx3 C14A inhibits the p97-dependent degradation of 
misfolded TCRα (Fig. S2) (DeLaBarre et al., 2006), a type I 
transmembrane protein targeted for retrotranslocation due to 
the lack of its assembly partners (Huppa and Ploegh, 1997). To 
this end, we expressed TCRα together with either FLAG-tagged 
wt atx3 or the atx3 C14A mutant in 293T cells. Quantitative 
immunoblotting using fl  uorescence-labeled secondary antibod-
ies showed that the FLAG-tagged atx3 variants were expressed 
 12-fold higher than the endogenous protein (unpublished 
data). When the level of TCRα was determined, it was indeed 
elevated in cells expressing atx3 C14A (Fig. 3 A, lane 2 vs. lane 1; 
Fig. 3 B, lane 2 vs. lane 1). A pulse-chase experiment confi  rmed 
that TCRα was more stable in atx3 C14A–expressing cells 
(Fig. S3, t1/2  60 min in atx3 C14A cells vs.  30 min in control 
cells). Because a signifi  cant fraction of the stabilized TCRα 
  appeared to carry polyubiquitin conjugates as determined by 
immunoblotting the precipitated TCRα with ubiquitin anti-
bodies (Fig. 3 A, lane 2; Fig. 3 B, lane 2), the stabilization effect 
by atx3 C14A was likely underestimated in the pulse-chase 
  experiment because only the nonubiquitinated TCRα species 
could be analyzed. In contrast to atx3 C14A, overexpression of 
wt atx3 only moderately stabilized TCRα (Fig. S3), and did not 
increase the level of ubiquitinated TCRα (Fig. 3 B, lane 3). atx3 
C14A–induced accumulation of ubiquitinated TCRα was more 
apparent when cells were treated with the proteasome inhibitor 
MG132 (Fig. 3 A, lane 4). Although MG132-treated control 
cells also contained a signifi  cant amount of the ubiquitinated 
TCRα, most substrates in these cells remained nonubiqui-
tinated, which included both the glycosylated retrotranslocation 
precursor molecules and the dislocated deglycosylated degrada-
tion intermediates (Fig. 3 A, lane 3). In contrast, atx3 C14A–
  expressing cells treated with MG132 accumulated more 
ubiquitinated TCRα molecules at a compensatory loss of the 
nonubiquitinated species (Fig. 3 A, lane 4 vs. lane 3). These 
data suggest that the deubiquitination of TCRα is inhibited in 
atx3 C14A–expressing cells, leading to the stabilization of 
TCRα in part as polyubiquitinated species.
To test for a direct involvement of atx3 in ERAD, we 
  examined its interaction with TCRα. Detergent extracts of cells 
expressing HA-tagged TCRα together with either wt atx3 or 
atx3 C14A were subjected to immunoprecipitation with HA 
 antibodies. Immunoblotting analysis showed that only a small frac-
tion of wt atx3 was coprecipitated with TCRα (Fig. 3 C, lane 3), 
whereas signifi  cantly more atx3 C14A was bound to TCRα 
(Fig. 3 C, lane 2). These results are consistent with the concept 
that the atx3 C14A mutant is able to sequester its substrates in a 
stable complex. Treatment of cells with MG132 stabilized TCRα 
(Fig. 3 C, lanes 4–6 vs. lanes 1–3), and further enhanced the 
 interaction  between  TCRα and atx3 C14A (Fig. 3 C, lane 5 vs. 
lane 2). In contrast, the association of TCRα with wt atx3 re-
mained weak (Fig. 3 C, lane 6). These data suggest that atx3 
transiently binds TCRα to directly regulate its degradation.
To see whether atx3 also plays a role in degradation of 
soluble ERAD substrates, we examined the degradation of mis-
folded  β-site amyloid precursor protein cleaving enzyme 
(BACE457∆) (Molinari et al., 2003) in cells expressing either 
wt atx3 or atx3 C14A. Similar to TCRα, BACE457∆ was stabi-
lized in atx3 C13A–expressing cells, and a signifi  cant fraction 
of the accumulated BACE457∆ contained polyubiquitin conju-
gates (Fig. 3 D, lane 3). In contrast, expression of wt atx3 only 
moderately increased the level of nonubiquitinated BACE457∆ 
(Fig. 3 D, lane 2 vs. lane 1). Thus, atx3 is also involved in the 
degradation of lumenal ERAD substrates.
Because a defect in ERAD is usually associated with the 
accumulation of misfolded proteins in the ER, which triggers 
ER stress, we monitored the ER stress level in cells expressing 
atx3 C14A to further confi  rm its involvement in ERAD. Indeed, 
expression of atx3 C14A caused strong induction of an ER 
stress reporter gene, pGL3-GRP78 (-132)-luciferase (Fig. 3 E). 
Expression of wt atx3 also induced ER stress, albeit to a much 
lesser degree. This is consistent with the observation that wt 
atx3 caused a moderate stabilization of TCRα and BACE457∆. 
Together, these results further support the notion that the 
Figure 2.  atx3 interacts with the components of the retrotranslocation 
pathway at the ER membrane. (A) atx3 binds Derlin-1, VIMP, and p97. 
Detergent extracts of 293T cells transfected (trans.) with indicated plasmids 
were subjected to immunoprecipitation (IP) with anti-FLAG antibodies to 
enrich atx3 and its associated proteins. A fraction of the extracts (WCE, 
whole cell extract, 15%) was analyzed directly by immunoblotting (IB). Aster-
isks, IgG. (B) Interaction of endogenous atx3 with Derlin-1 and p97. As in 
A, except that dog pancreatic ER membranes were used. Bracket indicates 
different atx3 isoforms. (C) Interaction of atx3 with Hrd1. As in A, except that 
cells transfected with the indicated plasmids were used, and that immuno-
precipitation was performed with anti-Myc antibody. Asterisks, IgG.JCB • VOLUME 174 • NUMBER 7 • 2006  966
  deubiquitinating activity of atx3 may be essential for effi  cient 
elimination of misfolded ER proteins.
The inhibition of ERAD by atx3 C14A cannot be attrib-
uted to general perturbation of the ubiquitin proteasome system 
by the overexpressed defective DUB, because the proteasome-
dependent degradation of an N-end rule substrate Ub-R-GFP 
(Dantuma et al., 2000) was not affected (Fig. 3 F). Interestingly, 
the degradation of Ub-R-GFP could be inhibited by a p97 mu-
tant that was defective in ATP hydrolysis (QQ). Thus, the inhib-
itory effect of atx3 C14A on protein degradation cannot be 
simply due to nonselective disruption of p97 function by the 
overexpressed mutant protein.
atx3 promotes p97-associated 
deubiquitination
Because atx3 is a p97-associated DUB (Burnett et al., 2003), 
it may facilitate ERAD by promoting deubiquitination of 
  substrates bound by p97. To examine p97-associated deubiqui-
tination (PAD), p97 and its associated proteins were immuno-
precipitated from cell extracts and analyzed by immunoblotting. 
A fraction of the precipitated material carried polyubiquitin 
conjugates. Because these ubiquitinated proteins were not 
  detected when immunoprecipitation was performed under de-
naturing condition, they were likely substrates bound to p97 
(Fig. S4, available at http://www.jcb.org/cgi/content/full/
jcb.200605100/DC1). Next, we tested whether these ubiqui-
tinated proteins could be subjected to deubiquitination in vitro 
by DUBs coprecipitated with p97. Indeed, the amount of p97-
bound ubiquitinated material was slowly reduced during incu-
bation (Fig. 4 A, lanes 1–4), a process that could be blocked 
by N-ethylmaleimide, an inhibitor of deubiquitination (unpub-
lished data). To test whether atx3 can facilitate this process, p97 
and its associated substrates purifi   ed from cells expressing 
  either wt atx3 or atx3 C14A mutant were tested for in vitro 
  deubiquitination. Expression of wild type, but not the catalytically 
inactive atx3 mutant, accelerated the decay of these ubiquitin 
conjugates (Fig. 4 A, lanes 5–8 vs. lanes 1–4; Fig. 4 B; Fig. S5). 
These data indicate that atx3 indeed facilitates PAD. Notably, 
a smaller amount of ubiquitinated proteins was coprecipitated 
with p97 from cells  expressing wt atx3 (Fig. 4 A, lane 5 vs. lane 1; 
Figure 3.  atx3 C14A interferes with ERAD and 
triggers ER stress. (A) Expression of atx3 C14A 
stabilizes TCRα. HA-tagged TCRα from cells trans-
fected (trans.) with indicated plasmids was immuno-
precipitated with HA antibodies and analyzed by 
immunoblotting (IB) (TCRα+CHO, glycosylated 
TCRα; TCRα-CHO, deglycosylated TCRα). Where 
indicated, cells were treated with MG132 (10 μM) 
for 14 h. (B) atx3 C14A inhibits deubiquitination 
of TCRα. Cell extracts were denatured before 
  being subjected to immunoprecipitation as in A. 
(C) Interaction of atx3 with TCRα. HA-TCRα was 
immunoprecipitated with HA antibodies from de-
tergent extracts of cells transfected with indicated 
plasmids. Asterisk, IgG. (D) atx3 C14A inhibits the 
degradation of BACE457∆. As in B, except that 
cells expressing BACE457∆ together with the indi-
cated atx3 variants were analyzed. In addition, a 
GFP-expressing plasmid was included to control 
the transfection efﬁ  ciency, and a ubiquitin-expressing 
plasmid was cotransfected to increase the level 
of ubiquitinated BACE457∆. WCE, whole cell 
  extract. (E) atx3 C14A induces ER stress. 293T 
cells were transfected with an ER stress reporter 
plasmid pGL3-GRP78 (-132) luciferase (Yoshida 
et al., 2001) together with indicated constructs. 
A GFP-expressing construct was also included to 
monitor the transfection efﬁ  ciency. Luciferase activ-
ity in cell extracts was determined 24 h after trans-
fection. The graph represents three independent 
experiments normalized to the GFP level. (F) atx3 
C14A does not affect the degradation of Ub-R-
GFP.   Detergent extracts of cells expressing Ub-R-
GFP  together with indicated proteins were analyzed 
by immunoblotting.ATAXIN-3 REGULATES ER-ASSOCIATED PROTEIN DEGRADATION • WANG ET AL. 967
Fig. 4 C, lane 3 vs. lane 1), suggesting that atx3-mediated 
PAD may also occur in intact cells. Expression of USP14, a 
DUB primarily associated with the proteasome (Borodovsky 
et al., 2001; Leggett et al., 2002), did not decrease the amount of 
ubiquitinated proteins bound to p97 (Fig. 4 C, lane 5 vs. lane 1), 
and did not increase the rate of PAD in vitro (Fig. 4 C, lanes 5 
and 6). Together, these data suggest that atx3 can promote PAD 
both in intact cells and in vitro.
To understand how atx3 cooperates with p97 to promote 
deubiquitination, we wished to determine the order between 
atx3-mediated deubiquitination and p97-dependent ATP hydro-
lysis. We reasoned if atx3 acts subsequent to the ATPase cycle 
of p97, inhibition of p97 ATPase activity would likely prevent 
ubiquitinated substrates from reaching the enzymatic site of 
atx3 because substrates cannot be released from p97 under this 
condition (Ye et al., 2001). To test this idea, FLAG-tagged 
wt atx3 was coexpressed together with either His-tagged 
wt p97 or a p97 mutant defective in ATP hydrolysis (QQ) (Ye 
et al., 2001). The amount of ubiquitinated substrates associated 
with His-tagged p97 was determined. The expression of atx3 
reduced the amount of ubiquitinated proteins associated with 
wt p97 (Fig. 4 D, lane 2 vs. lane 1), but not of those bound by p97 
QQ (lane 4 vs. lane 3), although more atx3 was bound by p97 
QQ (lane 4 vs. lane 2). Moreover, the expression of p97 QQ re-
sulted in more ubiquitinated proteins in association with atx3 
and p97 (Fig. 4 E, lane 5 vs.  lane 1), and these ubiquitinated 
proteins were more resistant to deubiquitination in vitro (Fig. 
4 E, lanes 5–8 vs. lanes 1–4; Fig. 4 F). These data indicate that 
ubiquitinated substrates  accumulated upon p97 QQ expression 
cannot be effi  ciently deubiquitinated by atx3. Although these 
Figure 4.  atx3 acts downstream of p97 to promote PAD. (A) atx3 promotes deubiquitination associated with p97. 293T cells were transfected (trans.) with 
the indicated plasmids. p97 and its associated proteins were immunoprecipitated (IP) and subjected to in vitro deubiquitination. (B) Quantiﬁ  cation of experi-
ment in A. (C) USP14 has no effect on p97-associated deubiquitination. Cells transfected with either an empty vector (control), FLAG-tagged atx3, or FLAG-
tagged USP14 were analyzed as in A. A fraction of the cell extract (whole cell extract) was directly analyzed by immunoblotting. (D) A p97 mutant 
defective in ATP hydrolysis (QQ) blocks atx3-mediated PAD. His-tagged wt p97 or p97 QQ mutant was immunoprecipitated from detergent extracts of cells 
transfected with either a control vector (−) or a FLAG-tagged atx3 construct (+). Asterisk, IgG (E) p97 QQ inhibits atx3-dependent deubiquitination in vitro. 
FLAG-tagged atx3 and its associated proteins were immunoprecipitated from detergent extracts of cells expressing either wt p97 or p97 QQ, and subjected 
to in vitro deubiquitination. (F) Quantiﬁ  cation of the experiment in E.JCB • VOLUME 174 • NUMBER 7 • 2006  968
substrates can be coimmunoprecipitated with atx3, they are 
likely still bound by the p97 QQ mutant, which is also present 
in the complex. Thus, ATP hydrolysis by p97 appears to pre-
cede atx3-mediated deubiquitination. Perhaps p97-dependent 
ATP hydrolysis is coupled to the transfer of substrates to the 
enzymatic site of atx3. Because the p97 ATPase cycle is re-
quired for the extraction of misfolded proteins from the ER 
membranes (Ye et al., 2001), atx3 likely acts at a step down-
stream of dislocation.
Regulated association of atx3 
with the ER membrane
We noticed that more atx3 was bound to the p97 QQ than to 
wt p97 (Fig. 4 D, lane 4 vs. 2; Fig. 4 E). In addition, an increased 
association between atx3 and VIMP was observed in cells 
  expressing p97 QQ (Fig. 5 A, lane 3 vs. lanes 1 and 2). Conse-
quently, more atx3 was found in association with the ER mem-
brane in these cells (Fig. 5 B, lane 5 vs. lanes 1 and 3). These 
data indicate that the association of atx3 with p97 and VIMP at 
the ER membrane may be regulated by the p97 ATPase cycle, a 
conclusion that is also supported by the recent observation that 
the interaction of p97 with atx3 in brain extracts is enhanced 
when ATP or ATPγS is present (Boeddrich et al., 2006). 
Because atx3 bound purifi  ed wt p97 and the p97 QQ mutant with 
similar affi  nity in vitro (Fig. 1 A), the enhanced interaction be-
tween atx3 and p97 QQ mutant may require additional factors 
present in cells. Interestingly, mutant atx3 lacking its deubiqui-
tinating activity (C14A) also exhibited an increased affi  nity to 
p97, VIMP, and Derlin-1 (Fig. S5; Fig. 5 C). Consistent with 
this fi  nding, atx3 C14A also accumulated at the ER membrane 
to a much higher level than wt atx3 (Fig. 5 D, lane 3 vs. lane 1). 
The simplest explanation of these observations is that a small 
fraction of atx3 is transiently associated with the ER membrane 
via interactions with p97 and VIMP. atx3 may shuttle on and off 
p97 to promote PAD, a process that is linked to the ATPase 
  cycle of p97 and to the subsequent delivery of substrates to the 
proteasome. Mutations affecting the enzymatic activity of either 
p97 or atx3 appear to interfere with the release of atx3 from 
p97, which may also prevent substrates from leaving p97 
(see following paragraph).
atx3 C14A blocks the transfer 
of substrates from p97 to the proteasome
To test whether atx3 C14A inhibits ERAD by interfering with 
the transfer of substrates from p97 to the proteasome, we deter-
mined the relative amount of ubiquitinated substrates bound to 
p97 versus those bound by the proteasome. We reasoned that 
a defect in substrate transfer would lead to an accumulation 
of ubiquitinated substrates in complex with p97. Detergent ex-
tracts of 293T cells were subjected to immunoprecipitation with 
antibodies to either p97 or α6, a subunit of the 20S proteasome. 
Immunoblotting showed that the α6 antibodies precipitated α7, 
another subunit of the 20S proteasome, together with Mms1, a 
subunit of the 19S particle, but not p97. Likewise, antibodies 
against p97 precipitated the ATPase itself, some Mms1, and 
no α7 (Fig. 6 A). These data confi  rm that p97 and the 26S 
  proteasome do not form a stable complex. When ubiquitinated 
proteins were examined, control cells contained little polyubiq-
uitinated proteins, and they were evenly distributed between the 
proteasome and p97 (Fig. 6 A, lane 2 vs. lane 1). In contrast, 
atx3 C14A–expressing cells contained more ubiquitinated 
  proteins, and they were almost entirely associated with p97 
(Fig. 6 A, lanes 3 and 4; Fig. 6 B).  The increased association 
of p97 with ubiquitinated proteins cannot be simply due to the 
accumulation of ubiquitinated proteins in cells expressing a 
  defective DUB, because  overexpression of the catalytically 
Figure 5.  Regulated association of atx3 with 
the ER membrane. (A) A dominant-negative 
p97 mutant (QQ) enhances the association 
between VIMP and atx3. Detergent extracts of 
293T cells transfected (trans.) with FLAG-
tagged atx3 together with the indicated plas-
mids were subjected to immunoprecipitation 
(IP) with VIMP antibodies. A fraction of the ex-
tract (WCE) was analyzed directly by immuno-
blotting (IB). (B) p97 QQ increases the level of 
membrane-bound atx3. Cells transfected with 
the indicated plasmids were homogenized in a 
low salt buffer. The post-nuclear extracts were 
fractionated into a membrane fraction (M) and 
a cytosolic fraction (C) before being analyzed 
by immunoblotting. (C) atx3 C14A exhibits 
  increased afﬁ  nity to p97, Derlin-1, and VIMP. 
As in A, except that cells transfected with the 
indicated plasmids were analyzed, and that 
anti-FLAG antibodies were used for immuno-
precipitation. (D) Enhanced association of 
atx3 C14A with the ER membrane. As in B, ex-
cept that cells transfected with the indicated 
plasmids were used.ATAXIN-3 REGULATES ER-ASSOCIATED PROTEIN DEGRADATION • WANG ET AL. 969
  inactive USP14 mutant (USP14 C114A) also increased the 
level of   ubiquitinated proteins, but did not cause an apparent 
  accumulation of ubiquitinated proteins in complex with p97 
(Fig. 6 B). These data indicate that atx3 C14A likely blocks the 
transfer of substrates from p97 to the proteasome, leading to 
their stabilization.
Discussion
We have investigated the role of atx3 in retrotranslocation of 
misfolded ER proteins. We show that atx3 interacts with the 
 recently  identifi  ed retrotranslocation complex consisting of 
Derlin-1, VIMP, certain ER-specifi  c ubiquitin ligases, and the 
pulling ATPase p97 in the ER membrane. A direct involvement 
of atx3 in ERAD is suggested by its binding to model ERAD 
substrates en route to the proteasome. Moreover, expression 
of a mutant atx3 defective in deubiquitination (atx3 C14A) 
  dramatically inhibits the degradation of both membrane and 
  lumenal ERAD substrates. Consequently, ER stress is induced 
in these cells. ERAD substrates stabilized by mutant atx3 are 
accumulated in part as polyubiquitinated degradation interme-
diates, suggesting that atx3 acts on these substrates to remove 
their ubiquitin conjugates. Intriguingly, ubiquitinated proteins 
accumulated upon mutant atx3 expression are sequestered in 
complex with p97, raising the possibility that atx3-mediated 
deubiquitination may be coupled to the transfer of substrates 
from p97 to the proteasome.
The observation that overexpression of wt atx3 moder-
ately inhibits ERAD is unexpected, but is not without prece-
dence. In fact, overexpression of rad23, an atx3-interacting 
partner that facilitates the delivery of ubiquitinated proteins 
to the proteasome (Elsasser and Finley, 2005), also inhibits 
protein turn-over. Recent studies suggest that the effect of 
rad23 on protein degradation is highly dependent on its con-
centration, with low concentrations being stimulatory and 
high concentrations inhibitory (Verma et al., 2004). The inhi-
bition of ERAD by wt atx3 may be similarly caused by its 
overexpression, which may titrate out certain factors essential 
for ERAD. Alternatively, the deubiquitinating activity of atx3 
may need to be tightly regulated in conjunction with other 
  reactions to mediate the degradation of ERAD substrates 
(see following paragraph). The presence of excessive atx3 
may uncouple deubiquitination from these processes, which 
may cause a defect in ERAD.
We propose that atx3 may promote deubiquitination of 
p97-bound substrates to facilitate their transfer to the protea-
some during retrotranslocation (Fig. 7). In this model, atx3 
would fi  rst interact with p97, which is prebound to its substrates 
together with Derlin-1 and VIMP at the ER membrane. In the 
next step, substrates may be transferred from p97 to atx3, a pro-
cess that is likely associated with the p97 ATPase cycle. Next, 
atx3 would act on the ubiquitinated substrates, which might be 
subsequently transferred to a downstream ubiquitin receptor 
such as rad23. Because ubiquitin chains consisting of at least 
four ubiquitin molecules are required for effi  cient targeting of 
modifi  ed substrates to the proteasome, deubiquitination of sub-
strates en route to the proteasome by atx3 is likely tightly cou-
pled to the transfer process to ensure that the targeting signal 
is not prematurely erased. In S. cerevisiae, ubiquitin chains on 
substrates of cdc48p appear to be progressively shortened while 
the substrates are in transit to the proteasome (Richly et al., 
2005). In light of this fi  nding, we speculate that atx3 may func-
tion as an editing enzyme to trim ubiquitin conjugates on 
  substrates to guide them to the proteasome. Although atx3 im-
munoprecipitated from mammalian cells appears to deubiqui-
tinate its substrates completely, recombinant atx3 purifi  ed from 
bacteria indeed exhibits chain trimming activity, leading to a 
shortening of ubiquitin chains rather than to their complete 
  removal (Burnett, et al., 2003). Because atx3 binds the ubiquitin-
like domain of rad23, which also mediates the interaction 
  between rad23 and the proteasome (Doss-Pepe et al., 2003), it 
is likely that rad23 may not interact with atx3 and the protea-
some simultaneously.
Our analysis demonstrates a physiological function for 
atx3. We postulate that the expression of the poly-Q–expanded 
Figure 6.  atx3 is involved in transferring ubiquitinated proteins from p97 
to the proteasome. (A) atx3 C14A causes the accumulation of ubiqui-
tinated proteins in association with p97. Ubiquitinated proteins associated 
with p97 and the proteasome were immunoprecipitated (IP) with anti-p97 
and anti-α6 antibodies, respectively. A fraction of the extracts (WCE) was 
analyzed directly by immunoblotting (IB) (B) USP14 C114A does not in-
crease the level of p97-associated ubiquitinated proteins. Ubiquitinated 
proteins bound to p97 in cells transfected with the indicated plasmids were 
immunoprecipitated and analyzed by immunoblotting.JCB • VOLUME 174 • NUMBER 7 • 2006  970
atx3 mutants may also impair ERAD and trigger ER stress, 
which may contribute to the pathogenesis of spinocerebellar 
ataxia. Further analysis of these mutants will help to clarify the 
long-suspected connection between ER stress and neurodegen-
erative diseases.
Materials and methods
Constructs
The plasmids pcDNA3.1 His-p97 wt and pcDNA3.1 His-p97 QQ were 
described previously (Ye et al., 2004). The plasmid pRK-FLAG atx3 wt 
(consisting of 20 CAG repeat) was constructed by cloning the human 
atx3 cDNA (a gift from R. Pittman, University of Pennsylvania, Philadel-
phia, PA; Burnett et al., 2005) into the SalI and NotI sites of the pRK-
FLAG vector (a gift from H. Shu, the National Jewish Medical Center, 
Denver, CO). pRK-FLAG-USP14 was constructed by cloning the human 
USP14 cDNA into the SalI and NotI sites of the pRK-FLAG vector. pRK-
FLAG-atx3 C14A and pRK-FLAG-USP14 C114A were constructed by 
site-directed mutagenesis using the QuikChange mutagenesis kit from 
Stratagene. All plasmids were sequenced. HA-tagged TCRα clone was a 
gift from R. Kopito (Stanford University, Stanford, CA; Yu et al., 1997). 
pGL-3-GRP78 (-132) luciferase plasmid was provided by K. Mori (Kyoto 
University, Kyoto, Japan). Plasmids expressing Ub-R-GFP, GST-SVIP, and 
BACE457∆ were provided by N. Dantuma (Karolinska Institute, Stockholm, 
Sweden), M. Nagahama (Tokyo University of Pharmacy and Life Science, 
Tokyo, Japan), and M. Molinari (Institute for   Research in   Biomedicine, 
Bellinzona, Switzerland), respectively.
Antibodies and chemicals
Anti-BACE antibody was a gift from P. Paganetti (Novartis Pharma AG, 
  Basel, Switzerland). Antibodies to ubiquitin, p97, Ufd1, and VIMP were 
described previously (Ye et al., 2004, 2005). Rabbit polyclonal antibodies 
to Derlin-1 were raised against a peptide corresponding to residues 
238–251 of the human Derlin-1. All antibodies used in this study were af-
ﬁ  nity puriﬁ  ed using the corresponding antigenic peptides. FLAG, HA, and 
GFP antibodies were purchased from Sigma-Aldrich, Roche, and Invitrogen, 
respectively. MG132 was purchased from Calbiochem.
Protein puriﬁ  cation and in vitro binding experiments
The puriﬁ  cation of His-tagged p97 variants and the Ufd1–Npl4 complex 
has been described previously (Ye et al., 2003). GST-atx3 was puriﬁ  ed 
  according to standard procedure using glutathione beads. GST pull-down 
experiments were performed as described previously (Ye et al., 2005). 
In brief, GST fusion proteins (5 μg) bound to glutathione beads were 
  incubated with various puriﬁ   ed recombinant proteins in 50 mM Hepes 
(pH 7.3), 150 mM potassium chloride, 2.5 mM magnesium chloride, 5% 
glycerol, and 0.1% Triton X-100. Bound material was analyzed by 
SDS/PAGE and stained with Coomassie blue.
Mammalian cell culture, transient gene expression, fractionation, 
and coimmunoprecipitation
293T cells were maintained according to standard procedures. Transfec-
tions in 293T cells were done with Trans IT (Mirus). For fractionation 
  experiments, cells were homogenized by passing through a 25G needle 
in a low salt buffer (50 mM Hepes, pH 7.4, 10 mM potassium chloride, 
1 mM DTT, and a protease inhibitor). Cell extracts were then subjected 
to sequential centrifugation at different speeds. For coimmunoprecipita-
tion experiments, tissue culture cells or dog pancreatic microsomes 
were   extracted with buffer N (30 mM Tris/HCl, pH 7.4, 150 mM potas-
sium acetate, 4 mM magnesium acetate, 1% DeoxyBigCHAP, and a 
  protease inhibitor cocktail). To detect ubiquitinated ΤCRα, cell extracts 
were   adjusted to contain 0.2% SDS, 0.5 mM DTT, and 5 mM N-ethylma-
leimide. Samples were heated at 95°C before being subjected to immuno-
precipitation. To isolate the 26S proteasome, 2 mM ATP was included 
in the   extraction buffer to preserve the interaction between the 19S and 
the 20S proteasome particles. All cell extracts were cleared by centrifuga-
tion (20,000 g) and subjected to immunoprecipitation with various anti-
bodies. Immunoblots were visualized with a cooled CCD digital camera 
system (LAS-3000; Fuji). Results were quantiﬁ  ed using MultiGauge v3.0 
software (Fuji).
In vitro deubiquitination experiments
To detect p97 or atx3-associated deubiquitination, cells were extracted 
with buffer N. Cell extracts were subjected to immunoprecipitation with 
either p97 antibodies or anti-FLAG antibody to isolate p97 or FLAG-
tagged atx3. Proteins bound to the beads were incubated in a deubiqui-
tinating buffer (50mM Tris/HCl, pH 7.4, 20mM potassium chloride, 5mM 
magnesium chloride, 1mM DTT, 2.5% BSA) at 37°C. Deubiquitination 
was stopped by addition of SDS sample buffer. Samples were analyzed 
by immunoblotting.
Online supplemental material
Fig. S1 shows that knock-down of atx3 by  80% by siRNA has little effect 
on the degradation of TCRα. Fig. S2 shows that the degradation of TCRα 
requires p97. Fig. S3 provides evidence that the accumulation of TCRα in 
atx3 C14A–expressing cells is due to its stabilization. Fig. S4 shows the 
association of p97 with ubiquitinated proteins. Fig. S5 demonstrates that 
an atx3 mutant defective in deubiquitination fails to promote PAD. Online 
supplemental material is available at http://www.jcb.org/cgi/content/
full/jcb.200605100/DC1.
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Figure 7.  A working model for the role of atx3 in ERAD. 
atx3 transiently associates with p97 together with its sub-
strates at the ER membrane. For certain substrates, the com-
plex likely also contains the Derlin–VIMP complex. After the 
p97-dependent dislocation, substrates may be transferred to 
atx3, which will shorten the ubiquitin chains on the substrates. 
This process may be coupled to the delivery of the substrates 
to an ubiquitin receptor such as rad23 on the proteasome. 
Mutations affecting either the ATPase cycle of p97 or the deu-
biquitinating activity of atx3 would prevent substrates from 
reaching the proteasome.ATAXIN-3 REGULATES ER-ASSOCIATED PROTEIN DEGRADATION • WANG ET AL. 971
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